Behavioral
One Love Periodic Services INC
One Love Periodic Services INC was paid $16.75M by Medicaid between Jan 2018 and Dec 2024, across 14 billing codes. Its largest line is H2022, Community-based wrap-around services, per diem — 46% of everything it billed.
33Billing provider infoONE LOVE PERIODIC SERVICES INC
MORGANTON, NC 28655
MORGANTON, NC 28655
33aNPI1225187180assigned 01/09/2007
33bProvider typeCounselor
28Total paid$16.75M
24GClaims292,805
24DCodes billed14
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Counselor providers in North Carolina
Rank by total paid#9 of 123
Median peer was paid$318K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,371 | $657K | |
| 2019 | 7,733 | $1.50M | |
| 2020 | 10,487 | $1.49M | |
| 2021 | 142,428 | $5.00M | |
| 2022 | 111,806 | $4.32M | |
| 2023 | 8,287 | $1.75M | |
| 2024incomplete | 7,693 | $2.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H2022 | Community-based wrap-around services, per diem | 46% | 31,483 | 2,329 | $7.78M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 24% | 75,799 | 27,451 | $4.08M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.9% | 74,637 | 26,816 | $1.32M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 6.7% | 60,251 | 22,297 | $1.12M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 5.9% | 6,347 | 3,329 | $985K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.5% | 28,344 | 9,978 | $585K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.2% | 6,269 | 3,269 | $365K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.8% | 4,457 | 1,479 | $307K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 2,565 | 858 | $92K |
| 98968 | <1% | 1,514 | 422 | $59K | |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | <1% | 109 | 106 | $24K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 351 | 250 | $13K |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWIDEMAN, STEVIE (OWNER)